Latest News and Press Releases

Jeito Capital consolidates its support in CatalYm with a renewed participation in a $150 million financing This new financing will support broad late-stage clinical development program for...

Jeito Capital announces the acquisition by Merck & Co (NYSE: MRK)of its portfolio company EyeBio for a potential value of $3 billion This acquisition reflects the significant clinical progress...

Jeito Capital co-leads EUR 65 million (USD 711M) financing in Corteria Pharmaceuticals, a French biopharmaceutical company developing novel treatments for cardiovascular diseases Jeito Capital...

                                                             Jeito Capital leads a $105 million Series C financing in Alentis Therapeutics to advance transformational medicines for claudin-1 in...

                                                             Jeito Capital dirige un financement de série C de 96 millions d’euros (105 millions de dollars) dans Alentis Therapeutics pour développer...

                                                             Jeito Capital co-dirige un financement de 104 millions d’euros pour Noema Pharma, une biopharma ciblant les maladies graves du système...

                                                             Jeito Capital co-leads a EUR 104 million financing in Noema Pharma, a clinical-stage biopharma company targeting debilitating central...

Jeito Capital renforce son soutien à Pulmocide en participant à un nouveau financement de 52 millions de dollars Ce nouveau tour de table permettra d’accélérer le développement clinique et...

                                                            Jeito Capital strengthens its support in Pulmocide with participation in $52 million financing The Series C extension round will...

                                                             Jeito Capital affirme son leadership dans le secteur biopharmaceutique européen avec la cession de Neogene Therapeutics à AstraZeneca ...